
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Snapin CRISPR/Cas9 KO Plasmid (h) | sc-406317 | 20 µg | $397.00 |
SNAPIN encodes Snapin, a small cytosolic protein that associates with SNARE machinery and tethering complexes to support vesicle docking and regulated exocytosis, particularly in neurons and neuroendocrine cells. Snapin has been linked to synaptic vesicle priming, calcium-coupled neurotransmitter release, and endosome/lysosome-related trafficking through interactions that coordinate membrane fusion events. By influencing synaptic transmission and intracellular transport, SNAPIN is frequently studied in pathways relevant to neuronal connectivity, autophagy-lysosome function, and stress-responsive signaling. Altered Snapin-dependent trafficking has been investigated in the context of neurodevelopmental and neurodegenerative disease mechanisms where vesicle transport and proteostasis are disrupted.
Snapin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SNAPIN gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SNAPIN together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SNAPIN open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Snapin protein expression.
This CRISPR knockout system enables efficient generation of SNAPIN-deficient cell models for investigation of Snapin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.